Important Update on Listing Status and Strategic Direction
03. Januar 2024 07:00 ET
|
Nemaura Medical, Inc
Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs,...
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
13. Dezember 2023 08:00 ET
|
Nemaura Medical, Inc
Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital...